Quantinuum Inc. (NASDAQ:QNT) drew bullish analyst reactions after its second-quarter results, with analysts pointing to stronger revenue visibility, rising bookings and a major Oracle Cloud Infrastructure partnership as signs of growing commercial momentum.
Quantinuum reported an adjusted loss of 28 cents per share, wider than the 26-cent loss expected by analysts. Revenue reached $8 million, topping the $7.598 million estimate and rising 279% from a year earlier.
The company forecast full-year 2026 revenue of $28 million to $32 million, above the $26.485 million analyst estimate.
Quantinuum ended June with $2.1 billion in cash, cash equivalents and short-term investments.
Analysts at Rosenblatt Securities and TD Cowen maintained bullish ratings following the report. Rosenblatt reiterated its Buy rating and $155 price forecast, while TD Cowen maintained a Buy rating without assigning a price forecast.
Quantinuum A ‘Core Quantum Name To Own’: Rosenblatt
Rosenblatt said Quantinuum delivered a strong “beat and raise” in its first quarter as a public company, with revenue coming in 5% above consensus.
The firm said the company’s 2026 revenue outlook midpoint was 13% above the $26.5 million consensus estimate. Quantinuum also provided an initial 2027 outlook calling for revenue growth of more than 100%, compared with Street expectations of about 68% growth.
Rosenblatt said rising bookings are also improving visibility. Second-quarter bookings reached $4.3 million, nearly triple the first quarter’s $1.3 million. Cumulative bookings reached about $81 million after the quarter, including the Oracle agreement and other deals. Management expects at least $120 million in bookings for 2026, up from $79 million in 2025.
The analyst called Quantinuum a “core quantum name to own,” citing its commercial backlog, Oracle partnership and progress toward its next-generation systems. Rosenblatt said its confidence in the company’s technology roadmap and financial estimates increased following the quarter.
Oracle Deal Validates Quantinuum Technology
Rosenblatt highlighted Oracle Corporation’s (NYSE:ORCL) decision to buy a Helios system for deployment in a U.S. Oracle Cloud Infrastructure data center.
The firm called Oracle a discerning technology customer and said its selection of Helios provides strong validation for Quantinuum’s technology. Rosenblatt expects limited revenue from the agreement in 2026, with a greater contribution around system delivery in 2027.
The system will be tightly integrated with OCI’s compute, networking, storage, identity and data services. The companies aim to support quantum, artificial intelligence and high-performance computing workflows in areas including pharmaceuticals, molecular discovery, materials science and energy.
TD Cowen Sees GenAI Opportunity Materializing
TD Cowen also highlighted Quantinuum’s stronger-than-expected outlook and improving visibility into 2027.
The firm said the midpoint of Quantinuum’s 2026 revenue forecast exceeded expectations and was supported by $81 million in cumulative bookings. TD Cowen said the company’s backlog and customer pipeline provided enough visibility for management to forecast revenue growth of more than 100% in 2027.
TD Cowen described the Oracle partnership as a major customer win because of both its revenue potential and its role in quantum-enhanced generative AI computing. The firm said successful development could open new use cases, expand Quantinuum’s software and algorithm expertise and drive broader adoption of its quantum computing services.
The analyst also sees potential for additional on-premise system sales to hyperscalers, sovereign customers, research institutions and enterprises. TD Cowen said Quantinuum’s latest Helios system offers about 50 high-fidelity logical qubits, creating scope for its 2027 prospects to expand further.
Quantum Roadmap Remains On Track
Analysts also pointed to progress on Quantinuum’s technology roadmap.
The Sol quantum processing unit remains targeted for the second half of 2027, with early chips undergoing testing and validation. Apollo remains scheduled for 2029.
Quantinuum said it demonstrated near-five-nines logical fidelity on Helios and that Sol’s trap chip has returned from fabrication and entered product validation. The company also said Apollo remains on schedule for 2029.
Rosenblatt said those developments are gradually reducing technology-roadmap risk and strengthening the path toward commercially relevant quantum computing. The firm maintained its $155 price forecast, implying substantial upside from Quantinuum’s $56.06 closing price on Aug. 11.
Price Action
QNT Stock Price Activity: Quantinuum shares were up 21.94% at $68.36 at the time of publication on Wednesday, according to Benzinga Pro data.
Photo via Shutterstock
Login to comment